Spinal zaps & cancer drug: new hope for kids with cerebral palsy?
NCT ID NCT07433023
Summary
This study is testing whether a combination of non-invasive spinal stimulation and a drug called 5-Azacitidine can improve walking and movement in children with cerebral palsy. 80 children, aged 4 to 17, will participate in a 16-week training program with weekly stimulation sessions. Some participants will also be randomly chosen to receive a single dose of the drug or a placebo to see if it boosts the effects of the stimulation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
Contact
Conditions
Explore the condition pages connected to this study.